Skip to content
Search

Latest Stories

Alex Potter is new MD at PharmAssist Solutions UK

Alex Potter is the new Managing Director of PharmAssist Solutions UK, an online purchasing solution utilised by over 1,100 community pharmacies. Potter, previously the Director of Digital at Phoenix UK, will succeed the current MD, Amar Randhawa, and has expertise in the digital landscape across the industry, PharmAssist Solutions said in a statement.

"We are delighted to have Alex on board," said Stuart Lucas, Chair of the PharmAssist Solutions Board. "His profound grasp of the pharmacy sector, combined with his expertise in digital innovation, will spearhead PharmAssist Solution's evolution to meet the dynamic demands of its clientele."


Meanwhile, Lucas expressed his gratitude and appreciation to Amar for his hard work and dedication over the last decade. "Amar, as the founder of PharmAssist Solutions, played a pivotal role in achieving numerous significant milestones and driving its growth," he added. "We wish him every success in his future endeavors."

"Alex’s profound expertise in the digital realm will undoubtedly propel PharmAssist Solutions to new heights," added Jeremy Main, Independent NED for PharmAssist Solutions. "This appointment builds on the impressive legacy left by Amar, fortifying our capacity to deliver a top-tier service in the pharmacy sector."

PharmAssist Solutions is dedicated to furnishing pharmacy teams with state-of-the-art software solutions that foster business development and growth, the statement added.

Last week, Titan PMR, a technology firm specialising in PMR systems for community pharmacies, introduced 'Titanverse'. This platform aims to redefine pharmacy management by offering comprehensive solutions that extend beyond prescription management, and takes a versatile approach, efficiently handling all facets of pharmacy operations, from high-level management down to daily tasks, according to the company.

More For You

Walgreens Boots Alliance acquired by Sycamore in deal

Walgreens Boots Alliancehas entered into “a definitive agreement” to be acquired by Sycamore Partners

Gettyimages

Walgreens Boots Alliance acquired by Sycamore in £18.3 billion deal

Walgreens Boots Alliance(WBA) has entered into “a definitive agreement” to be acquired by Sycamore Partners, a private equity firm specializing in retail, consumer and distribution-related investments.

“The total value of the transaction represents up to $23.7 billion (£18.3 billion),” the company announced late last night (6).

Keep ReadingShow less
Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Lawrence Tallon named new MHRA chief executive

Lawrence Tallon

Photo credit: Sciana Network

Lawrence Tallon named new MHRA chief executive

Lawrence Tallon has been appointed as the new chief executive officer of the Medicines and Healthcare products Regulatory Agency (MHRA), effective 1 April 2025.

He will succeed Dame June Raine DBE, who is retiring after leading the agency since 2019.

Keep ReadingShow less